Synaptic Vulnerability in Neurodegenerative Disease
暂无分享,去创建一个
Thomas H. Gillingwater | Simon H. Parson | T. Gillingwater | T. Wishart | Thomas M. Wishart | S. Parson
[1] M. Mattson,et al. p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults , 2007, NeuroMolecular Medicine.
[2] G. Arbuthnott,et al. Delayed synaptic degeneration in the CNS of Wlds mice after cortical lesion. , 2006, Brain : a journal of neurology.
[3] J. Geddes,et al. Synaptic Mitochondria Are More Susceptible to Ca2+Overload than Nonsynaptic Mitochondria* , 2006, Journal of Biological Chemistry.
[4] Kevin A. Robertson,et al. The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells. , 2006, Human molecular genetics.
[5] Pico Caroni,et al. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF , 2006, Nature Neuroscience.
[6] R. Ribchester,et al. The neuroprotective Wld S gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells , 2006 .
[7] J. Harris,et al. Envenoming bites by kraits: the biological basis of treatment-resistant neuromuscular paralysis. , 2005, Brain : a journal of neurology.
[8] Thomas C. Südhof,et al. α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.
[9] Xinran Liu,et al. Progressively reduced synaptic vesicle pool size in cultured neurons derived from neuronal ceroid lipofuscinosis-1 knockout mice , 2005, Neurobiology of Disease.
[10] M. Coleman. Axon degeneration mechanisms: commonality amid diversity , 2005, Nature Reviews Neuroscience.
[11] E. Masliah,et al. β-Amyloid Immunotherapy Prevents Synaptic Degeneration in a Mouse Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.
[12] R. Balice-Gordon,et al. Neuromuscular synaptogenesis in wild-type and mutant zebrafish. , 2005, Developmental biology.
[13] Raymond A. Dwek,et al. Storage solutions: treating lysosomal disorders of the brain , 2005, Nature Reviews Neuroscience.
[14] Michael D. Ehlers,et al. Ubiquitin and Protein Turnover in Synapse Function , 2005, Neuron.
[15] A. Singleton. Altered α-synuclein homeostasis causing Parkinson's disease: the potential roles of dardarin , 2005, Trends in Neurosciences.
[16] Marc Vidal,et al. Systematic analysis of genes required for synapse structure and function , 2005, Nature.
[17] C. Culmsee,et al. p53 in neuronal apoptosis. , 2005, Biochemical and biophysical research communications.
[18] Stanley I. Rapoport. Le fonctionnement synaptique évalué par l’imagerie fonctionnelle du cerveau dans la maladie d’Alzheimer , 2005 .
[19] H. Willison. The immunobiology of Guillain‐Barré syndromes , 2005, Journal of the peripheral nervous system : JPNS.
[20] Timothy H Murphy,et al. Rapid Reversible Changes in Dendritic Spine Structure In Vivo Gated by the Degree of Ischemia , 2005, The Journal of Neuroscience.
[21] R. Fetter,et al. Presynaptic Spectrin Is Essential for Synapse Stabilization , 2005, Current Biology.
[22] W. K. Cullen,et al. Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo , 2005, Nature Medicine.
[23] R. Ribchester,et al. Progressive loss of motor neuron function in wasted mice: effects of a spontaneous null mutation in the gene for the eEF1 A2 translation factor. , 2005, Journal of neuropathology and experimental neurology.
[24] S. Cheema,et al. Loss of synaptophysin‐positive boutons on lumbar motor neurons innervating the medial gastrocnemius muscle of the SOD1G93A G1H transgenic mouse model of ALS , 2005, Journal of neuroscience research.
[25] A. Musarò,et al. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model , 2005, The Journal of cell biology.
[26] B. Ghetti,et al. Bax deletion prevents neuronal loss but not neurological symptoms in a transgenic model of inherited prion disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[27] Jun Xie,et al. RNAi knockdown of Par‐4 inhibits neurosynaptic degeneration in ALS‐linked mice , 2005, Journal of neurochemistry.
[28] Hitoshi Osaka,et al. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice. , 2004, Brain : a journal of neurology.
[29] E. Masliah,et al. Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[30] W. K. Cullen,et al. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. , 2005, Nature medicine.
[31] T. Südhof,et al. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. , 2005, Cell.
[32] A. Singleton. Altered alpha-synuclein homeostasis causing Parkinson's disease: the potential roles of dardarin. , 2005, Trends in neurosciences.
[33] S. Rapoport. [In vivo imaging for evaluating synaptic integrity in Alzheimer disease]. , 2005, Psychologie & neuropsychiatrie du vieillissement.
[34] Christoph Schmitz,et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS , 2005, Nature Neuroscience.
[35] Thomas H Gillingwater,et al. Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation , 2004, The European journal of neuroscience.
[36] Roger Kurlan,et al. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias , 2004, Neurology.
[37] J. Kordower,et al. Early changes in Huntington’s disease patient brains involve alterations in cytoskeletal and synaptic elements , 2004, Journal of neurocytology.
[38] S. Ohara,et al. Axonal dystrophy of dorsal root ganglion sensory neurons in a mouse model of Niemann–Pick disease type C , 2004, Experimental Neurology.
[39] Coleman Mp,et al. Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system. , 2004 .
[40] Structural dynamics of synapses in living animals , 2004, Current Opinion in Neurobiology.
[41] T. Südhof,et al. The Synaptic Vesicle Protein CSPα Prevents Presynaptic Degeneration , 2004, Neuron.
[42] R. Ribchester,et al. Axotomy‐dependent and ‐independent synapse elimination in organ cultures of Wlds mutant mouse skeletal muscle , 2004, Journal of neuroscience research.
[43] G. Cole,et al. Rapid annexin-V labeling in synaptosomes , 2004, Neurochemistry International.
[44] J. Glass,et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man , 2004, Experimental Neurology.
[45] R. Ribchester,et al. Neuroprotection after Transient Global Cerebral Ischemia in Wlds Mutant Mice , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[46] T. Südhof,et al. The synaptic vesicle protein CSP alpha prevents presynaptic degeneration. , 2004, Neuron.
[47] S. Maruyama,et al. Synapse loss in anterior horn neurons in amyotrophic lateral sclerosis , 2004, Acta Neuropathologica.
[48] R. Ribchester,et al. Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system. , 2004, Current drug targets. CNS and neurological disorders.
[49] J. Sundsfjord,et al. 123I-β-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia , 2004, Psychopharmacology.
[50] S. Scheff,et al. Synaptic pathology in Alzheimer’s disease: a review of ultrastructural studies , 2003, Neurobiology of Aging.
[51] V. Sossi,et al. [11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease. , 2003, Brain : a journal of neurology.
[52] Christian Haass,et al. Games Played by Rogue Proteins in Prion Disorders and Alzheimer's Disease , 2003, Science.
[53] Patrik Brundin,et al. Huntington's disease: a synaptopathy? , 2003, Trends in molecular medicine.
[54] J. Melki,et al. Riluzole attenuates spinal muscular atrophy disease progression in a mouse model , 2003, Muscle & nerve.
[55] F. Gage,et al. Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model , 2003, Science.
[56] K. Davies,et al. Neuromuscular defects in a Drosophila survival motor neuron gene mutant. , 2003, Human molecular genetics.
[57] R. Ribchester,et al. The relationship of neuromuscular synapse elimination to synaptic degeneration and pathology: Insights from WldS and other mutant mice , 2003, Journal of neurocytology.
[58] J. Melki,et al. Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy. , 2003, Human molecular genetics.
[59] V. Perry,et al. Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease , 2003, The European journal of neuroscience.
[60] D. Mitter,et al. The synaptophysin/synaptobrevin interaction critically depends on the cholesterol content , 2002, Journal of neurochemistry.
[61] V. Sossi,et al. DTBZ-PET correlates of levodopa responses in asymmetric Parkinson ' s disease , 2003 .
[62] K. Svoboda,et al. Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex , 2002, Nature.
[63] C. Fletcher,et al. Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease , 2002, Nature Genetics.
[64] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[65] D. Tagle,et al. PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains. , 2002, Human molecular genetics.
[66] R. Ribchester,et al. Age‐Dependent Synapse Withdrawal at Axotomised Neuromuscular Junctions in Wlds Mutant and Ube4b/Nmnat Transgenic Mice , 2002, The Journal of physiology.
[67] H. Mizukami,et al. Neuroprotective Effects of Glial Cell Line-Derived Neurotrophic Factor Mediated by an Adeno-Associated Virus Vector in a Transgenic Animal Model of Amyotrophic Lateral Sclerosis , 2002, The Journal of Neuroscience.
[68] H. Uylings,et al. Neuronal Changes in Normal Human Aging and Alzheimer's Disease , 2002, Brain and Cognition.
[69] J. Melki,et al. Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model. , 2002, Human molecular genetics.
[70] D. Muller,et al. Remodeling of Hippocampal Synaptic Networks by a Brief Anoxia–Hypoglycemia , 2002, The Journal of Neuroscience.
[71] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[72] I. Akiguchi,et al. Differential expression between synaptic vesicle proteins and presynaptic plasma membrane proteins in the anterior horn of amyotrophic lateral sclerosis , 2002, Acta Neuropathologica.
[73] M. Chesselet,et al. Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. , 2001, Journal of neurophysiology.
[74] M. Lehtovirta,et al. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease. , 2001, Human molecular genetics.
[75] E. Bigio,et al. Contribution of asymmetric synapse loss to lateralizing clinical deficits in frontotemporal dementias. , 2001, Archives of neurology.
[76] R. Ribchester,et al. Compartmental neurodegeneration and synaptic plasticity in the Wlds mutant mouse , 2001, The Journal of physiology.
[77] Y. Maruyama,et al. Changes in presynaptic proteins, SNAP-25 and synaptophysin, in the hippocampal CA1 area in ischemic gerbils , 2001, Brain Research.
[78] Paolo Guidetti,et al. Early Degenerative Changes in Transgenic Mice Expressing Mutant Huntingtin Involve Dendritic Abnormalities but No Impairment of Mitochondrial Energy Production , 2001, Experimental Neurology.
[79] E. Masliah,et al. Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease , 2001, Neurology.
[80] M. Lehtovirta,et al. Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL). , 2001, Human molecular genetics.
[81] Kang Hu,et al. High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.
[82] M. Pinter,et al. Functional motor unit failure precedes neuromuscular degeneration in canine motor neuron disease , 2000, Annals of neurology.
[83] M. Mattson. Apoptotic and Anti‐Apoptotic Synaptic Signaling Mechanisms , 2000, Brain pathology.
[84] P. Caroni,et al. Early and Selective Loss of Neuromuscular Synapse Subtypes with Low Sprouting Competence in Motoneuron Diseases , 2000, The Journal of Neuroscience.
[85] A. Johnston,et al. Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie‐infected murine hippocampus , 2000, Neuropathology and applied neurobiology.
[86] M. Haltia,et al. Human prion diseases , 2000, Annals of medicine.
[87] M. Mattson,et al. Caspase and calpain substrates: Roles in synaptic plasticity and cell death , 1999, Journal of neuroscience research.
[88] Gary Lynch,et al. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice , 1999, Brain Research.
[89] R. Motter,et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.
[90] J. Mcculloch,et al. Drug development for stroke: importance of protecting cerebral white matter. , 1999, European journal of pharmacology.
[91] M. Iwata,et al. Ultrastructural change of synapses of Betz cells in patients with amyotrophic lateral sclerosis , 1999, Neuroscience Letters.
[92] M. Mattson,et al. Prostate Apoptosis Response‐4 Production in Synaptic Compartments Following Apoptotic and Excitotoxic Insults , 1999, Journal of neurochemistry.
[93] T. Bliss,et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice , 1999, Nature Neuroscience.
[94] R. Brady,et al. Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann- Pick type C disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[95] E. Bigio,et al. Neocortical Synapse Density and Braak Stage in the Lewy Body Variant of Alzheimer Disease: A Comparison with Classic Alzheimer Disease and Normal Aging , 1998, Journal of neuropathology and experimental neurology.
[96] M. Mattson,et al. Evidence for Synaptic Apoptosis , 1998, Experimental Neurology.
[97] B. Miller,et al. Frontotemporal dementia: Neuropil spheroids and presynaptic terminal degeneration , 1998, Annals of neurology.
[98] S. Hirai,et al. Loss of Cholinergic Synapses on the Spinal Motor Neurons of Amyotrophic Lateral Sclerosis , 1998, Journal of neuropathology and experimental neurology.
[99] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[100] S. DeArmond,et al. Workshop 4: Human Prion Diseases , 1994 .
[101] S. Prusiner,et al. Human prion diseases , 1994, Annals of neurology.
[102] D. Richman,et al. Neuromuscular transmission in amyotrophic lateral sclerosis , 1993, Muscle & nerve.
[103] M. Royston,et al. Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study. , 1993, Neuroreport.
[104] R. Shin,et al. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. , 1992, The American journal of pathology.
[105] N W Kowall,et al. Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[106] D. Salmon,et al. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.
[107] S. DeKosky,et al. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.
[108] D. Mann,et al. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease , 1987, Journal of the Neurological Sciences.
[109] G. Graveland,et al. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. , 1985, Science.